Literature DB >> 18298079

Latrunculin A and its C-17-O-carbamates inhibit prostate tumor cell invasion and HIF-1 activation in breast tumor cells.

Khalid A El Sayed1, Mohammad A Khanfar, Hassan M Shallal, A Muralidharan, Bhushan Awate, Diaa T A Youssef, Yang Liu, Yu-Dong Zhou, Dale G Nagle, Girish Shah.   

Abstract

The marine-derived macrolides latrunculins A ( 1) and B, from the Red Sea sponge Negombata magnifica, have been found to reversibly bind actin monomers, forming a 1:1 complex with G-actin and disrupting its polymerization. The microfilament protein actin is responsible for several essential functions within the cell such as cytokinesis and cell migration. One of the main binding pharmacophores of 1 to G-actin was identified as the C-17 lactol hydroxyl moiety that binds arginine 210 NH. Latrunculin A-17- O-carbamates 2- 6 were prepared by reaction with the corresponding isocyanates. Latrunculin A ( 1) and carbamates 4- 6 displayed potent anti-invasive activity against the human highly metastatic human prostate cancer PC-3M cells in a Matrigel assay at a concentration range of 50 nM to 1 microM. Latrunculin A ( 1, 500 nM) decreased the disaggregation and cell migration of PC-3M-CT+ spheroids by 3-fold. Carbamates 4 and 5 were 2.5- and 5-fold more active than 1, respectively, in this assay with less actin binding affinity. Latrunculin A ( 1, IC 50 6.7 microM) and its 17- O-[ N-(benzyl)carbamate ( 6, IC 50 29 microM) suppress hypoxia-induced HIF-1 activation in T47D breast tumor cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18298079      PMCID: PMC2930178          DOI: 10.1021/np070587w

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  36 in total

Review 1.  The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions.

Authors:  I Alroy; Y Yarden
Journal:  FEBS Lett       Date:  1997-06-23       Impact factor: 4.124

2.  HIF-1 alpha is required for solid tumor formation and embryonic vascularization.

Authors:  H E Ryan; J Lo; R S Johnson
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

3.  Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity.

Authors:  Benjamin J Moeller; Matthew R Dreher; Zahid N Rabbani; Thies Schroeder; Yiting Cao; Chuan Y Li; Mark W Dewhirst
Journal:  Cancer Cell       Date:  2005-08       Impact factor: 31.743

4.  Calcitonin increases tumorigenicity of prostate cancer cells: evidence for the role of protein kinase A and urokinase-type plasminogen receptor.

Authors:  Shibu Thomas; Srinivasulu Chigurupati; Muralidharan Anbalagan; Girish Shah
Journal:  Mol Endocrinol       Date:  2006-03-30

5.  Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line.

Authors:  P M Ghosh; N Ghosh-Choudhury; M L Moyer; G E Mott; C A Thomas; B A Foster; N M Greenberg; J I Kreisberg
Journal:  Oncogene       Date:  1999-07-15       Impact factor: 9.867

6.  The cross talk between protein kinase A- and RhoA-mediated signaling in cancer cells.

Authors:  Yongchang Chen; Ying Wang; Hao Yu; Fengwei Wang; Wenrong Xu
Journal:  Exp Biol Med (Maywood)       Date:  2005-11

Review 7.  Pyrroloiminoquinone and related metabolites from marine sponges.

Authors:  Edith M Antunes; Brent R Copp; Michael T Davies-Coleman; Toufiek Samaai
Journal:  Nat Prod Rep       Date:  2005-01-04       Impact factor: 13.423

8.  Bioactive natural and semisynthetic latrunculins.

Authors:  Khalid A El Sayed; Diaa T A Youssef; Dario Marchetti
Journal:  J Nat Prod       Date:  2006-02       Impact factor: 4.050

Review 9.  Development of novel therapeutic strategies that target HIF-1.

Authors:  Gregg L Semenza
Journal:  Expert Opin Ther Targets       Date:  2006-04       Impact factor: 6.902

10.  Actin-depolymerizing factor and cofilin-1 play overlapping roles in promoting rapid F-actin depolymerization in mammalian nonmuscle cells.

Authors:  Pirta Hotulainen; Eija Paunola; Maria K Vartiainen; Pekka Lappalainen
Journal:  Mol Biol Cell       Date:  2004-11-17       Impact factor: 4.138

View more
  22 in total

Review 1.  Bioactive Compounds from Marine Heterobranchs.

Authors:  Conxita Avila; Carlos Angulo-Preckler
Journal:  Mar Drugs       Date:  2020-12-21       Impact factor: 5.118

2.  Marine Natural Products as Inhibitors of Hypoxic Signaling in Tumors.

Authors:  Dale G Nagle; Yu-Dong Zhou
Journal:  Phytochem Rev       Date:  2009-06       Impact factor: 5.374

3.  3D-QSAR studies of latrunculin-based actin polymerization inhibitors using CoMFA and CoMSIA approaches.

Authors:  Mohammad A Khanfar; Diaa T A Youssef; Khalid A El Sayed
Journal:  Eur J Med Chem       Date:  2010-05-12       Impact factor: 6.514

4.  Hypoxia induces Wee1 expression and attenuates hydrogen peroxide-induced endothelial damage in MS1 cells.

Authors:  Ki Sun Hong; Hyeon Soo Kim; Se Hoon Kim; Dong Jun Lim; Jung Yul Park; Sang Dae Kim
Journal:  Exp Mol Med       Date:  2011-12-31       Impact factor: 8.718

5.  Natural product libraries to accelerate the high-throughput discovery of therapeutic leads.

Authors:  Tyler A Johnson; Johann Sohn; Wayne D Inman; Samarkand A Estee; Steven T Loveridge; Helene C Vervoort; Karen Tenney; Junke Liu; Kenny Kean-Hooi Ang; Joseline Ratnam; Walter M Bray; Nadine C Gassner; Young Y Shen; R Scott Lokey; James H McKerrow; Kyria Boundy-Mills; Arif Nukanto; Atit Kanti; Heddy Julistiono; Leonardus B S Kardono; Leonard F Bjeldanes; Phillip Crews
Journal:  J Nat Prod       Date:  2011-11-30       Impact factor: 4.050

Review 6.  Targeting the cytoskeleton against metastatic dissemination.

Authors:  Carmen Ruggiero; Enzo Lalli
Journal:  Cancer Metastasis Rev       Date:  2021-01-20       Impact factor: 9.264

7.  Semisynthetic latrunculin derivatives as inhibitors of metastatic breast cancer: biological evaluations, preliminary structure-activity relationship and molecular modeling studies.

Authors:  Mohammad A Khanfar; Diaa T A Youssef; Khalid A El Sayed
Journal:  ChemMedChem       Date:  2010-02-01       Impact factor: 3.466

8.  Development and validation of a rapid method for the detection of latrunculol A in plasma.

Authors:  Jiajiu Shaw; Frederick A Valeriote; Joseph Media; Tyler A Johnson; Taro Amagata; Karen Tenney; Phillip Crews
Journal:  Anal Bioanal Chem       Date:  2009-12-31       Impact factor: 4.142

9.  Targeting cancer cell adhesion molecule, CD146, with low-dose gold nanorods and mild hyperthermia disrupts actin cytoskeleton and cancer cell migration.

Authors:  Jinyuan Liu; Lin Kang; Ishara Ratnayake; Phil Ahrenkiel; Steve Smith; Congzhou Wang
Journal:  J Colloid Interface Sci       Date:  2021-05-26       Impact factor: 8.128

10.  Total synthesis of (+)-18-epi-latrunculol A: development of a synthetic route.

Authors:  Brett D Williams; Amos B Smith
Journal:  J Org Chem       Date:  2014-09-22       Impact factor: 4.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.